Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Cagrilintide/semaglutide

A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight

Novo Nordisk · Phase 3 · Completed · Enrollment 300

NCT06388187

ArmPopulationDoseWeeksEstimandWeight change
CagriSema Dose 1Obesity or overweightn/r60n/rn/r
Placebo Dose 1Obesity or overweightn/r60n/rn/r
CagriSema Dose 2Obesity or overweightn/r60n/rn/r
Placebo Dose 2Obesity or overweightn/r60n/rn/r